Drugs / Recombinant Follicle Stimulating Hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02412904 | Jan → Dec 2014 | infertility disorder | Hospital de Clinicas de Porto Alegre | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Follicle Stimulating Hormone | “Phase 4 Study Comparing Recombinant Follicle Stimulating Hormone (rFSH) or Ultra-pure to HMG in Patients Submitted to IVF Using Gnrh Antagonist” NCT02412904 ↗ |
| Known as | rFSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02412904 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Follicle Stimulating Hormone (rFSH)” NCT02412904 ↗ |